Endeavor

New Study Suggests Socioeconomic Status Affects Access to Leukemia Transplant, Not Survival

Researchers point to access to care as a major issue for people in lower socioeconomic brackets

Hard-to-Treat Lymphoma Patients Benefit From New Immunotherapy

AZD0486 demonstrates high response rates in relapsed/refractory diffuse large B-cell lymphoma, including patients who failed CAR-T therapy

Moffitt Experts Share Latest Blood Cancer Advancements at ASH Annual Meeting

Novel therapies and innovative approaches take center stage in multiple hematologic malignancies

Study Reveals Key Insights Between New Blood Condition and Lower-Risk Myelodysplastic Syndromes

High-risk CCUS patients by CHRS and CCRS risk stratification tools have similar characteristics and outcomes to patients with lower-risk MDS

Moffitt Experts Conduct First Analysis on New Criteria for Chronic Myelomonocytic Leukemia

Study finds patients who were switched to a chronic myelomonocytic leukemia diagnosis based on the new criteria more so resembled myelodysplastic syndromes genetically.

Moffitt Researchers Find Breakthrough Treatment for Aggressive Blood Cancers

Promising combo therapy and innovative tracking techniques offer new hope for patients

Moffitt Study Finds New Genetic Clues to Resistance in Multiple Myeloma Treatments

Study reveals genetic markers that predict treatment resistance, offering potential for more personalized therapy plans

New CAR T-Cell Therapy Shows Promising Results for Advanced Multiple Myeloma

Early trial results show high success rates and manageable side effects

Personalized Vaccine Shows Promise in Early HER2-Positive Breast Cancer

Dendritic cell vaccine uses immune cells collected from the patient, which are enhanced in the lab and injected directly into the primary breast tumor